Skadden Reps JLL Partners In $115M Health Buy-And-Build

Law360, New York (February 12, 2013, 5:13 PM EST) -- Private equity firm JLL Partners on Tuesday commenced a tender offer for BioClinica Inc. that values the manager of clinical trials at about $115 million and will allow it to be merged with another recently acquired health care company.

JLL Partners, a New York-based private equity firm with about $4 billion of capital and a focus on healthcare and pharma deals, will pay Pennsylvania-based BioClinica stockholders $7.25 per share. The tender offer follows a merger agreement signed Jan. 30.

JLL is also acquiring CoreLab Partners Inc., a...
To view the full article, register now.